Stock · NSE

GLENMARK

2,282.90▲ 15.70 (0.69%)

Last 2 days · 15m candles10/7/2026, 22:31:07

Open: 2,272.60High: 2,300.90Low: 2,255.10Prev: 2,267.20

Positive

Neutral

Negative

News mentioning GLENMARK

Sentiment: -11%← All news

VERIFIEDET Stocks·2d★ ON YOUR LIST

Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma

AI summary· NEUTRAL

·Cochin Shipyard's offer for sale received strong investor demand on its first day.
·Adani Enterprises' US legal case is likely to be dismissed by federal prosecutors.
·IDFC First Bank has launched provident fund payment services through its EPFO integration.

ADANIENT IDFCFIRSTB GLENMARK

VERIFIEDET Markets·2d★ ON YOUR LIST

Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma

AI summary· NEUTRAL

·Cochin Shipyard's offer for sale received strong investor demand on its first day.
·Adani Enterprises' US legal case is likely to be dismissed by federal prosecutors.
·IDFC First Bank has launched provident fund payment services through its EPFO integration.

ADANIENT IDFCFIRSTB GLENMARK

VERIFIEDMint Companies·3d★ ON YOUR LIST

Beyond generics: Glenmark resets agenda with a bold 10-year pivot to global drug innovation, says chairman Saldanha

AI summary· NEUTRAL

·Glenmark is pivoting towards global drug innovation with a 10-year plan.
·The strategy involves licensing deals, partnerships, and commercialization in emerging markets.
·Chairman Glenn Saldanha outlined the company's future direction.

GLENMARK

VERIFIEDET Finance·4d★ ON YOUR LIST

Glenmark launches generic Olanzapine injection in US

AI summary· NEUTRAL

·Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States.
·The injection is a treatment for schizophrenia and bipolar disorder.
·This launch aims to expand Glenmark's injectable offerings and institutional market presence.

GLENMARK

VERIFIEDMint Markets·38d★ ON YOUR LIST

After a dull Q4, Glenmark Pharma needs a booster shot to grow

AI summary· NEUTRAL

·Glenmark Pharma is focusing on core operational execution for FY27 growth.
·The company is looking past one-off licensing gains.
·Investors are shifting their focus to operational execution.

GLENMARK

VERIFIEDMint Markets·42d★ ON YOUR LIST

Q4 results today: Asian Paints, IndiGo, IREDA, Glenmark Pharma - 131 companies to announce earnings on 29 May

AI summary· NEUTRAL

·131 companies, including Asian Paints and IndiGo, will announce their Q4 results on May 29.
·Analysts anticipate a weak performance for Asian Paints due to urban demand challenges.
·NMDC's results are expected to provide insights into iron ore prices and demand trends.

ASIANPAINT INDIGO GLENMARK

VERIFIEDMint Markets·44d★ ON YOUR LIST

Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment

AI summary· NEGATIVE

·Gift Nifty indicates a lower opening for the Indian market, down 97 points at 23,882.
·Benchmark indices experienced a decline due to profit-taking and increasing crude oil prices.
·Nifty 50 is encountering resistance at 24,100 and support at 23,800.

MPHASIS NIFTY GLENMARK

REFERENCEGoogle News, India stocks·47d★ ON YOUR LIST

Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma,... - Moneycontrol.com

TVSMOTOR GLENMARK EXIDEIND

VERIFIEDMint Markets·49d★ ON YOUR LIST

Stocks to buy for short term: Glenmark Pharma, Manappuram Finance … Ajit Mishra of Religare Broking suggests 3 shares

AI summary· NEUTRAL

·Ajit Mishra of Religare Broking has identified three stocks for short-term gains.
·Glenmark Pharmaceuticals is among the stocks recommended.
·Manappuram Finance is also highlighted as a potential short-term investment.

GLENMARK MANAPPURAM